Form 4 Tracker
RxSight, Inc.
RXST

26 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 25, 2024Oct 25 8:15 PMILYA GOLDSHLEGER
Proposed Sale
3,100$49.79$154.4K—

View →

Oct 22, 2024Oct 22 8:16 PMILYA GOLDSHLEGER
Proposed Sale
3,100$49.68$154.0K—

View →

Oct 18, 2024Oct 18 8:23 PMILYA GOLDSHLEGER
Proposed Sale
3,105$50.09$155.5K—

View →

Oct 16, 2024Oct 16 8:16 PMILYA GOLDSHLEGER
Proposed Sale
3,100$49.78$154.3K—

View →

Oct 14, 2024Oct 15 12:23 PMILYA GOLDSHLEGER
Proposed Sale
3,100$50.09$155.3K—

View →

Oct 11, 2024Oct 11 8:17 PMILYA GOLDSHLEGER
Proposed Sale
3,100$50.19$155.6K—

View →

Oct 10, 2024Oct 10 8:11 PMILYA GOLDSHLEGER
Proposed Sale
3,105$48.82$151.6K—

View →

Oct 8, 2024Oct 8 8:19 PMILYA GOLDSHLEGER
Proposed Sale
3,100$48.26$149.6K—

View →

Oct 4, 2024Oct 4 8:23 PMILYA GOLDSHLEGER
Proposed Sale
3,100$48.01$148.8K—

View →

Oct 1, 2024Oct 1 8:24 PMSHELLEY B THUNEN
Proposed Sale
15,000$48.45$726.7K—

View →

Sep 30, 2024Sep 30 8:14 PMILYA GOLDSHLEGER
Proposed Sale
3,100$49.02$151.9K—

View →

Sep 26, 2024Sep 26 8:09 PMILYA GOLDSHLEGER
Proposed Sale
3,105$49.29$153.1K—

View →

Sep 23, 2024Sep 23 8:08 PMILYA GOLDSHLEGER
Proposed Sale
3,100$52.67$163.3K—

View →

Sep 20, 2024Sep 20 8:08 PMILYA GOLDSHLEGER
Proposed Sale
3,100$53.19$164.9K—

View →

Sep 17, 2024Sep 17 8:15 PMILYA GOLDSHLEGER
Proposed Sale
3,100$56.11$173.9K—

View →

Nov 12, 2024—ILYA GOLDSHLEGER
Proposed Sale
1,330$46.13$61.4K—

View →

Nov 4, 2024—ILYA GOLDSHLEGER
Proposed Sale
3,100$51.05$158.2K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 15, 2026Sep 16 8:25 PMEric WeinbergChief Business Development Officer
Option Exercise
35,168$4.340(D)

View →

Sep 5, 2026Sep 10 12:55 AMMark WilterdingChief Financial Officer
Disposition
258,770$10.090(D)

View →

Sep 5, 2026Sep 10 12:55 AMMark WilterdingChief Financial Officer
Grant/Award
258,770$6.38258,770(D)

View →

Sep 5, 2026Sep 10 12:55 AMEric WeinbergChief Business Development Officer
Disposition
449,637$56.070(D)

View →

Sep 5, 2026Sep 10 12:55 AMEric WeinbergChief Business Development Officer
Grant/Award
334,075$6.3893,984(D)

View →

Sep 5, 2026Sep 10 12:53 AMRonald M Kurtz MDChief Medical Officer
Grant/Award
686,447$6.38161,654(D)

View →

Sep 5, 2026Sep 10 12:53 AMRonald M Kurtz MDChief Medical Officer
Disposition
902,819$56.070(D)

View →

Sep 5, 2026Sep 10 12:53 AMIlya GoldshlegerChief Operating Officer
Grant/Award
364,032$6.3893,984(D)

View →

Sep 5, 2026Sep 10 12:53 AMIlya GoldshlegerChief Operating Officer
Disposition
485,567$56.070(D)

View →

Aug 31, 2026Sep 3 1:35 AMRonald M Kurtz MDChief Medical Officer
Option Exercise
13,425—67,120(D)

View →

Aug 31, 2026Sep 3 1:35 AMMark WilterdingChief Financial Officer
Option Exercise
20,441—122,646(D)

View →

Aug 31, 2026Sep 3 1:34 AMIlya GoldshlegerChief Operating Officer
Option Exercise
5,370—26,848(D)

View →

Aug 31, 2026Sep 3 1:33 AMEric WeinbergChief Business Development Officer
Option Exercise
5,370—26,848(D)

View →

Jul 24, 2026Jul 25 12:07 AMAziz MottiwalaDirector, President and CEO
Grant/Award
2,883,424$5.19571,286(D)

View →

Apr 17, 2026Apr 20 8:19 PMIlya GoldshlegerChief Operating Officer
Option Exercise
12,489$4.135(D)

View →

Feb 28, 2026Mar 4 1:24 AMMark WilterdingChief Financial Officer
Option Exercise
20,441—143,087(D)

View →

Feb 28, 2026Mar 4 1:22 AMScott GainesChief Customer Officer
Option Exercise
6,261—2,500(D)

View →

Feb 27, 2026Mar 4 1:22 AMScott GainesChief Customer Officer
Grant/Award
32,218—32,218(D)

View →

Feb 27, 2026Mar 4 1:21 AMIlya GoldshlegerChief Operating Officer
Grant/Award
32,218—32,218(D)

View →

Feb 27, 2026Mar 4 1:20 AMEric WeinbergExhibit 24 - Power of Attorney Chief Business Development Officer
Grant/Award
32,218—32,218(D)

View →

Page 1 of 2

Next →